Antimicrobial Agents and Chemotherapy, August 2007, p. 3001-3003, Vol. 51, No. 8
0066-4804/07/$08.00+0 doi:10.1128/AAC.00256-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
Changes in qnr Prevalence and Fluoroquinolone Resistance in Clinical Isolates of Klebsiella pneumoniae and Enterobacter spp. Collected from 1990 to 2005
Jacob Strahilevitz,1*
Dalia Engelstein,1
Amos Adler,1
Violeta Temper,1
Allon E. Moses,1
Colin Block,1 and
Ari Robicsek2
Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem 91120, Israel,1
Department of Medicine, Evanston Northwestern Healthcare, 2650 Ridge Ave., Evanston, Illinois 602012
Received 20 February 2007/
Returned for modification 5 April 2007/
Accepted 21 May 2007
Clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 through 2005 at a tertiary care center were studied for qnr genes. Isolates bearing these genes emerged in the mid-1990s, coinciding with the time of a rapid increase in fluoroquinolone resistance. Sixty percent of these isolates were ciprofloxacin susceptible by CLSI breakpoints.
* Corresponding author. Mailing address: Department of Clinical Microbiology and Infectious Diseases, Hadassah Ein-Kerem, Jerusalem 91120, Israel. Phone: 972-50-894 6353. Fax: 972-2-641 9545. E-mail: jstrahilevitz{at}hadassah.org.il
Published ahead of print on 25 May 2007.
Antimicrobial Agents and Chemotherapy, August 2007, p. 3001-3003, Vol. 51, No. 8
0066-4804/07/$08.00+0 doi:10.1128/AAC.00256-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Wu, J.-J., Ko, W.-C., Wu, H.-M., Yan, J.-J.
(2008). Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese Hospital, 1999-2005. J Antimicrob Chemother
61: 1234-1239
[Abstract]
[Full Text]
Copyright © 2007 by the American Society for Microbiology. All rights reserved.